Monitoring of safety using favipiravir: risk management of adverse drug reactions in clinical practice
Global experience with the clinical use of favipiravir is very limited. Its safety is for further study. Prevention of teratogenic effects (mandatory pregnancy test before starting therapy, compliance with effective contraception by both women and men), control of the level of uric acid, transaminas...
| Glavni autori: | , , , |
|---|---|
| Format: | Članak |
| Jezik: | Russian |
| Izdano: |
Izdatelstvo OKI
2020-10-01
|
| Serija: | Качественная клиническая практика |
| Teme: | |
| Online pristup: | https://www.clinvest.ru/jour/article/view/541 |